AN ACT relating to ibogaine research in the Commonwealth.

The Kentucky Legislature approved file SB77 ("AN ACT relating to ibogaine research in the Commonwealth."), by a recorded vote of 117 to 10. Last action: April 14, 2026.

Kentucky file SB77, before the Kentucky Legislature. Passed as of 2026-04-14.

Official summary

LRC summary of the enacted version: Creates new sections of KRS Chapter 218A to define terms; establish the ibogaine research and intellectual property fund, to be administered by the Department of Agriculture for the purpose of allowing the department to enter a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy; establish requirements for the department related to contracting with a drug developer regarding ibogaine research and intellectual property; require the drug developer to submit quarterly reports to the department; require the department to submit an annual report to the Legislative Research Commission on the progress and financial status of the drug development clinical trial or trials; and establish how proceeds from the commercialization of intellectual property created through the public-private partnership may be used.

How they voted

Yes (117)

No (10)

Did not vote / other (11)

Read the official record for SB77

See everything up for a vote · This week in Kentucky · See what we have filed with the clerk